Secukinumab sustains improvement in signs and symptoms of psoriatic arthritis: 2 year results from the phase 3 FUTURE 2 study.
| Image |  |
|---|---|
| Description | scientific article published on 16 August 2017 |
| Author/s |
author: Christopher T Ritchlin |
| Publication date | November 1, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |